Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17174 (
aspartate aminotransferase
)
14,872
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The genetics of lysosomal acid lipase (LIP) has been investigated in human-Chinese hamster and mouse-Chinese hamster somatic cell hybrids. Cellulose acetate electrophoresis of human fibroblast extracts demonstrated that LIP activity consists of three isozymes. A deficiency of LIP activity has been observed in Wolman's disease (WD), cholesterol ester storage disease (CESD), and I-cell disease (ICD); this deficiency was associated with only one LIP isozyme,
LIPA
. We have demonstrated concordant segregation between human
LIPA
and human chromosome 10 and its enzyme marker
glutamate oxaloacetate transaminase
-1 (GOT1) in cell hybrid clones. Previous evidence suggested the different mutations associated with WD and CESD to be in the structural gene which we assign to human chromosome 10, while a different gene, involved in the processing of
LIPA
, is altered in ICD. These results indicate that several types of gene products are involved in the final expression of
LIPA
. In mouse-Chinese hamster hybrid clones, mouse Lip-1 (homologous to human
LIPA
) was assigned to chromosome 19. Previously, mouse Got-1 has been assigned to chromosome 19. Thus, the
LIPA
-GOT1 linkage groups has remained intact during the 80 X 10(6) years of evolution that separates humans and mice.
...
PMID:Assignment of LIPA, associated with human acid lipase deficiency, to human chromosome 10 and comparative assignment to mouse chromosome 19. 729 52